XML 15 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Net cash used in operating activities $ (408,381) $ (779,339)
Cash flows from investing activities    
Investment in Equipment (1,638)
Investment in patents (1,891) (405)
Net cash used in investing activities (1,891) (2,043)
Cash flows from financing activities    
Payments on convertible notes (37,500)
Advances from shareholder 35,000
Proceeds from private placement offering 50,000 25,000
Net cash used in financing activities 85,000 (12,500)
Net change in cash (325,272) (793,882)
Cash and cash equivalents at beginning of period 409,039 1,276,654
Cash and cash equivalents at end of period 83,767 482,772
Supplemental Cash Flow Information    
Cash paid for interest 4,895 727
Cash paid for income taxes
Non-Cash Transactions    
Stock issued for accrued liabilities 93,250
Stock issued for advances from investors 100,000 25,000
Conversion of debt to common stock $ 100,000